Swiss Life Holding

Solid H1 20 figures, all targets confirmed despite COVID-19

13/08/20 -"• Net profit attributable to shareholders decreased by 13% to CHF533m for H1 20 • Gross written premiums were down by 17% for H1 20 due to a special Swiss effect in 2019 but +2% on an adjusted ..."

Published on
You may also be interested by these reports :
With the sale of the Singaporean operations for £1.6bn, the new CEO, Amanda Blanc, shows her intention to focus rapidly on its preferred markets (the ...

The improvement in the target price is driven by the downward revision in the applied discount relative to peers’ P/E and P/Book from 50% to 30%. ...

Scor has adjusted its strategic targets for 2020, taking into consideration the COVID-19 pansemic. The good news was the lower than booked emerging ...

CNP is still offering a significant upside potential thanks to its capacity to generate stable recurring operating profit. The presence of LBP as a ...


Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis


AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO